This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Planning for retirement in your 30s requires understanding key insights. Equip yourself with knowledge to secure a prosperous future.
18,862 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A widening gap between data-center demand and supply is boosting heavy equipment and power-management stocks. Discove...
A once-niche software play may be quietly building a full AI-driven financial platform. This software stock could del...
As tesla heads into july, the market faces a tug-of-war: robust quarterly deliveries versus pressure on margins and a...
Lionsgate faces a pivotal year as it balances streaming momentum with theatrical cycles and debt. This guide breaks d...
When a top executive sells a sizable stake, investors pay attention. This article unpacks the CFO's 50,000-share move...
Discover FitLife's 2025 earnings story, from revenue drivers to margins and cash flow. This guide breaks down what th...
Greg Abel is stepping into big shoes as Warren Buffett's successor. This article breaks down three bold purchases he ...
SpaceX is courting attention ahead of a potential Nasdaq debut. Some ETFs offer pre-IPO exposure via SPVs, but the st...
A once unimaginable moment is explored: spacex surpassed broadcom, meta on IPO day. This piece breaks down what that ...
A fresh deal and growing demand for nuclear fuel have sparked a notable move in centrus energy group stock. This arti...
As AI infrastructure expands, CoreWeave sits at a pivotal point. This guide identifies three key risks investors shou...